BCX10013
- Generic Name
- BCX10013
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
BCX10013 is a small molecule inhibitor of human complement factor D.
- Associated Conditions
- -
- Associated Therapies
- -
Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- BioCryst Pharmaceuticals
- Target Recruit Count
- 8
- Registration Number
- NCT06100900
- Locations
- 🇿🇦
BioCryst Investigative Site, Pretoria, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath